SALA DE PRENSA DE RENOWN

Renown Health Cardiology has received the American Heart Association’s Get With The Guidelines® - Heart Failure Gold Plus quality achievement award for its commitment to improving outcomes for patients with heart failure, meaning reduced readmissions and more healthy days at home. The heart care team also received Target: Heart Failure Honor Roll and Target: Type 2 Diabetes Honor Roll. About 6 million U.S. adults are living with heart failure (HF), a number that is expected to increase to more than 8 million by 2030. Despite the name, HF doesn’t mean that the heart has stopped working – it means the heart is having a hard time pumping blood and oxygen throughout the body. While there’s no cure for HF, patients can live a quality life by working with their health care team to create and stick with a plan that may include medication, symptom monitoring and lifestyle changes. The Get With The Guidelines - Heart Failure quality achievement award is earned by hospitals that demonstrate a commitment to treating patients according to the most up-to-date guidelines as outlined by the American Heart Association. Get With The Guidelines puts the expertise of the American Heart Association to work for hospitals nationwide, helping ensure patient care is aligned with the latest research- and evidence-based guidelines. The program aims to increase healthy days at home and reduce hospital readmissions for heart failure patients. “Renown Health is committed to improving patient care by adhering to the latest treatment guidelines,” said Jayson Morgan, MD, Director of Cardiovascular Services at Renown Health. “Get With The Guidelines makes it easier for our teams to put proven knowledge and guidelines to work on a daily basis, which studies show can help patients recover better. The end goal is to ensure more people in northern Nevada can experience longer, healthier lives.” Each year, program participants qualify for the award recognition by demonstrating how their organization has committed to providing quality care for HF patients. In addition to following treatment guidelines, Get With The Guidelines participants also provide education to patients to help them manage their HF at home. “We are pleased to recognize the leaders and teams at Renown Health for a strong commitment to caring for people with heart failure,” said Clyde W. Yancy, MD, MSc, MACC, FAHA, MACP, FHFSA, national chairperson of the American Heart Association Heart Failure systems of care advisory group and chief, division of cardiology at Northwestern University, Feinberg School of Medicine. “Hospitals that participate in Get With The Guidelines quality improvement programs often see better patient outcomes, fewer readmissions and lower mortality rates – a win for health care systems, families and communities.” Renown Health is also recognized on the American Heart Association’s Target: Heart FailureSM Honor Roll. Hospitals on the Honor Roll meet specific criteria that improves medication adherence, provides early follow-up care and coordination and enhances patient education. The goal is to further reduce hospital readmissions and help patients improve their quality of life in managing this chronic condition. Renown Health additionally received the American Heart Association’s Target: Type 2 Diabetes Honor Roll™ award. Target: Type 2 Diabetes aims to ensure patients with Type 2 diabetes, who might be at higher risk for complications, receive the most up-to-date, evidence-based care when hospitalized due to heart disease or stroke. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. Acerca de Get With The Guidelines Get With The Guidelines® es el programa de mejora de calidad hospitalaria de la Asociación Estadounidense del Corazón y la American Stroke Association que proporciona a los hospitales las últimas pautas basadas en la investigación. Desarrollado con el objetivo de salvar vidas y acelerar la recuperación, Get With The Guidelines ha influido en la vida de más de 12 millones de pacientes desde 2001. For more information, visit heart.org.

Leer más About Renown Health Is Nationally Recognized for Its Commitment To Providing High-Quality Heart Failure Care With Three American Heart Failure Recognitions

Two vascular surgeons bring a quarter of a century of experience to patients and community. As part of a continuing focus to bring comprehensive care to patients experiencing cardiac and vascular disease across northern Nevada, Renown Health Department of Surgery and Renown Institute for Heart & Vascular announce that vascular surgeons, John C. Hansen, MD, FACS and Benjamin P. Jaquish, MD, FACS have joined Renown Health.  "Recognizing the significance of preventing, diagnosing and caring for people with heart and vascular disease, which continues to be on the rise and taking far too many lives, is of critical important to us at Renown," says Christos A. Galanopoulos, MD, MBA, MSc, FACS, VP, Chairman Department of Surgery at Renown Health. "Both Drs. Hansen and Jaquish are superb clinicians, skilled investigators, and effective educators. We are fortunate to have them helping to lead the growth of both the department and the Division of Vascular and Endovascular Surgery." Together, the vascular surgeons have more than 26 years of combined experience caring for northern Nevadans. Dr. Hansen has 20 years of experience in northern Nevada. He is a clinical associate professor of surgery at the University of Nevada, Reno School of Medicine (UNR Med) and currently serves as medical director of vascular and endovascular surgery for Renown Regional Medical Center. "Since 2002, Dr. Hansen has led our region with his expertise and knowledge of aortic stents, grafting for abdominal aortic aneurysms and thoracic aneurysms, as well as treating patients with carotid disease," says Jayson Morgan, MD, FACC, Director, Cardiovascular Services. "Dr. Hansen specializes in the comprehensive management of vascular disorders, including open and endovascular surgeries. He is meticulous, thorough, and compassionate in the extraordinary care he provides to patients. We are thrilled that he has joined the Institute for Heart & Vascular Health team at Renown." Dr. Hansen completed his fellowship in Vascular Surgery at the Mayo Clinic in Rochester, MN, and completed his residency in General Surgery at the University of South Carolina, Greenville. He graduated with his Doctor of Medicine from the University of North Carolina School of Medicine, Chapel Hill, and is board certified in both Surgery and Vascular Surgery from the American Board of Surgery and a Fellow of the American College of Surgeons. Dr. Hansen has an interest in complex and acute vascular surgery and is committed to expanding access to qualified vascular care in the region. His mission is to further develop and establish Renown as a premier vascular center in northern Nevada. "Dr. Jaquish has extensive experience in carotid artery disease, carotid endarterectomy, aortic aneurysm and dissection, and peripheral vascular disease," says Sam Obilie-Mante, MBA, MIS, RDCS, RVT, LBBP, VP Administrator, Cardiovascular Services. "Dr. Jaquish is intelligent, professional, conscientious, and always perseveres on behalf of his patients. How proud we are to have him bringing his time and talent to patients across Renown Health." Dr. Jaquish received both his B.S. in Biochemistry (2005), graduating Magna Cum Laude with his Doctor of Medicine (2009) from the University of Nevada, Reno School of Medicine. Dr. Jaquish completed his fellowship in General Surgery at Ascension St. John Hospital and Medical Center in Detroit and a fellowship in Vascular Surgery at Texas A&M at Baylor, Scott & White Hospitals in Temple, TX. He is board certified in both General Surgery and Vascular Surgery. Dr. Jaquish currently serves as Assistant Professor of Clinical Surgery for UNR Med. Dr. Jaquish is bilingual in Spanish, proficient in American Sign Language and serves as an instructor for Advanced Trauma Life Support. Why Vascular and Endovascular Care Matters to You People with complex and serious conditions of the blood vessels and lymph system (vascular diseases) often find the help they need from Renown Health's vascular and endovascular surgical team. Renown's experts provide coordinated and comprehensive treatment to people of all ages. Renown's surgeons use advanced technology to perform vascular and endovascular surgery, including complex stenting procedures, blood clot removal and bypass surgery. Conditions treated include peripheral artery disease, aortic disease, mesenteric disease, nutcracker syndrome and carotid artery disease. "Our expert vascular and endovascular surgeons and staff treat problems that extend from mild to the most critical of emergencies," says Adnan Akbar, MD, Chief Medical Officer for Renown Acute Care. "Specialized physicians including cardiologists, interventional radiologists, heart and vascular surgeons, emergency medicine and trauma surgeons, neurologists, radiologists, physical medicine and rehabilitation specialists, primary care providers, nurses and other clinicians work as a team to determine the best treatment plan for each patient. We encourage all patients to discuss with their primary care providers whether they should undergo formal screening for early vascular disease." "Renown's reputation as the region's vascular and endovascular care leader has been built over many years. We performed the area's first open-heart surgery, angioplasty, stent and valve replacements decades ago. Renown Regional offers incredible advancements like trans-catheter aortic valve replacement (TAVR) and trans-catheter mitral valve repair (TMVr) with MitraClip therapy, lifesaving alternatives to open-heart surgery for patients considered high-risk or inoperable," says Chris Nicholas, FACHE, Chief Executive Officer of Renown Regional Medical Center. "Offering the highest level of comprehensive care for patients experiencing cardiac and vascular disease, Renown developed its first division of cardiothoracic surgery dedicated to heart surgery patients in 2019." The Renown Institute for Heart & Vascular Health program now offers a Diagnostic Electrophysiology Lab; a Chest Pain Center using the D-SPECT® heart camera; multiple Interventional Labs; Heart Failure Program; several Cardiac Catheterization Labs; Interventional Cardiology and Cardiac Surgery when necessary; and the only Pritikin-certified Healthy Heart Program in the West, creating individualized rehabilitation plans tailored to each patient's needs, so they can exercise safely, eat healthy, manage stress and cook nourishing, balanced meals, all while gaining a healthy mindset. In the most recent US News & World Report Best Hospital rankings, Renown Regional Medical Center was named as the number one hospital in Nevada. Ningún otro hospital del estado cumplió con sus estrictos estándares para el ranking de 2021. Renown Health is High Performing, its highest rating possible, in eight procedures and conditions including Heart Failure, Colon Cancer Surgery and Chronic Obstructive Pulmonary Disease, Hip Replacement and Knee Replacement. La calificación de un hospital se basa en múltiples categorías de datos, que incluyen resultados de los pacientes, seguridad y volúmenes. Los hospitales calificados como sobresalientes eran significativamente mejores que el promedio nacional. Las instituciones que componen los rankings de Mejores Hospitales de 2021-22 se seleccionan de entre un conjunto de 4,523 instalaciones, que representan a casi todos los hospitales estadounidenses que brindan atención para pacientes hospitalizados. Los hospitales se evalúan en función de una amplia gama de afecciones y procedimientos, incluidas 16 áreas de especialidad médica. US News & World Report evaluó 58 hospitales en Nevada. Renown Health is Nevada's largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 6,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children's hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. Visite renown.org para obtener más información. The University of Nevada, Reno School of Medicine (UNR Med), Nevada's first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Desde 1969, UNR Med ha capacitado a más de 3,900 estudiantes, residentes y becarios. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu.

Leer más About Nationally Recognized Vascular Surgeons Join Renown Health

Donante crea el Helaine Greenberg Women’s Heart Center en Renown Health La Fundación de Renown Health se complace en anunciar la generosa donación de Helaine Greenberg, una filántropa local a quien le apasiona ayudar a mejorar y fortalecer la atención médica de las mujeres en el norte de Nevada. Esta donación ayudará a crear el Helaine Greenberg Women’s Heart Center en Renown Health, ubicado dentro del Heart & Vascular Institute. El centro, primero en su tipo, ofrecerá tratamiento especializado para el corazón a mujeres en el norte de Nevada. La enfermedad cardíaca es la causa principal de muerte en mujeres —se cobra una vida por minuto—, pero muchas mujeres no saben que los signos de un ataque cardíaco son diferentes en las mujeres que en los hombres. Según la revista de la Asociación Estadounidense del Corazón, casi el 71 % de las mujeres que tuvieron ataques cardíacos experimentó cansancio inusual en las semanas anteriores, el 50 % tuvo problemas para dormir y el 42 % sufrió falta de aire. Lo más importante es que aproximadamente el 43 % no tuvo dolor de pecho. Gracias a esta generosa donación, las mujeres ahora tendrán la oportunidad de recibir atención y educación ejemplar de proveedores de confianza en un lugar conveniente. Helaine’s generosity comes from her heart, and with a passion for improving the lives – and health of women. We are deeply grateful for this transformative gift. The opening of this Center will continue our mission of making a genuine difference in the health and well-being of women- and all those who love them- and the communities we serve. “Este generoso regalo nos permite proporcionar atención cardíaca y vascular especializada a mujeres embarazadas, que están luchando contra el cáncer de pecho o que sufren molestias en el pecho”, dijo Jayson Morgan, MD, director de Servicios Cardiovasculares. “Hay millones de mujeres que viven con enfermedades cardíacas o que están en riesgo de padecerlas. Es fundamental que empoderemos a las mujeres para que tomen el control de su salud cardíaca y que les enseñemos a todos los signos y los síntomas que presentan las enfermedades cardíacas en las mujeres”. Led by Dr. Danish Atwal, the Helaine Greenberg Women’s Heart Center at Renown Health provides specific treatments, therapies, and education for women. La Sra. Greenberg ha apoyado de manera constante la atención médica de la mujer. Hace solo tres años, donó una gran suma para apoyar a las mujeres y prevenir el cáncer de pecho mediante la creación de los Helaine Greenberg Breast Health Centers en las ubicaciones de Renown de 2nd Street y Vista, que llevan su nombre en su honor, y que prestan servicios de exámenes de detección, como mamografías 3D, ultrasonidos de mama completa automatizados y pruebas DEXA de densidad ósea para la osteoporosis. “La salud de las mujeres es muy importante para Helaine. La Fundación de Renown Health y los médicos y proveedores del Renown Medical Group agradecen su deseo de ayudar a las mujeres que luchan contra problemas cardíacos”, expresó Greg Walaitis, director de desarrollo. “Prevenir y reducir las afecciones médicas crónicas y promover la salud y el bienestar mejora significativamente la vida de las mujeres de todas las edades. Agradecemos a Helaine por sus contribuciones mientras seguimos luchando por la causa justa”. Para obtener más información sobre la Fundación de Renown Health o para hacer una donación, llame al 775-982-5545 o visite renorg.org./give.   Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región que brinda servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®.

Leer más About Lucha por una causa justa: filántropa local hace significativa donación para mejorar la salud cardíaca de las mujeres

Always listening to the voice of the patient, Renown Health is pleased to welcome any two patient supporters to visit their loved ones during their Renown medical visit, surgery, birthing or hospital stay. Renown continues to have extra safety measures in place to protect the health of patients, visitors and healthcare employees, and as the situation changes with COVID-19, these guidelines are subject to change. Under this updated visitor policy, patients no longer need to identify their supporters ahead of their arrival. Patients may receive more than two visitors per day; however, to help ensure adequate physical distancing, only two guests are asked to visit at a time. All people entering Renown sites must continue bringing and wearing a face mask for their entire visit, including inside patient rooms. Renown’s visitor policy updates were inspired by family members, who requested that the policy be expanded to encourage two family members per day to be able to visit a loved one who was hospitalized at Renown. The request was approved by Dr. Debra Adornetto-Garcia, Chief Nursing Officer and Dr. Paul Sierzenski, Chief Medical Officer, both of Acute Services. Con un alto porcentaje del personal hospitalario de Renown vacunado contra la COVID-19, el descenso de las hospitalizaciones de pacientes con COVID-19 y la comprensión de que la mejor comunicación es la que se produce en persona, a partir del 28 de abril de 2021, los hospitales y consultorios médicos de Renown permitirán dos visitantes, en lugar de uno, para todos los pacientes y han puesto en marcha medidas de seguridad adicionales para proteger a los pacientes, los visitantes y los empleados de atención médica. “We are pleased to expand our visitor policy and welcome two healthy adult patient supporters to accompany every patient to their Renown medical visit or hospital stay,” said Tony Slonim, MD, DrPH, President & CEO of Renown. “We are always looking to our patients’ lived experiences to help us address the health needs of our community. Just a few months ago, we were reminded by Darlene Randolph that the best care is ‘person-centered care’, which inspired us to be one of the first healthcare organizations in the nation to expand our visitor policy to all patients, including those with COVID-19. Today, we thank our patients’ family members for voicing the importance of a larger, connected support system to help foster the best healing environment for all patients.” “At Renown, the definition of ‘family’ is defined by the patient,” said Debra Adornetto-Garcia, DNP, RN, NEA-BC, AOCN, Chief Nursing Officer, Acute Services. “Our patients may have anyone they choose as their patient supporters, and these individuals serve as an invaluable extension of our care teams. Patient supporters are asked to partner with the patient’s healthcare team to assist in communicating to other family members and friends, participating in training and education activities and assisting the patient with complying with care and medication instructions.” “Visiting the hospital can be an anxious experience,” said Paul Sierzenski, MD, MSHQS, CPE, FACEP, Chief Medical Officer, Acute Services. “It’s incredible how the company of loved ones can reduce anxiety and promote healing. What we can do together with families to support patient care and excellent outcomes is greater than what any of us can do alone. We are glad to welcome patient supporters to our hospitals to help our patients feel more at ease, so they can focus on their recovery, health and healing.” Two patient supporters per patient are now able to access Renown campuses as noted: Renown Regional Medical Center and Renown South Meadows Medical Center: de 8 a.m. a 8 p.m. Para las unidades de cuidados intensivos (UCI): de9 a.m. a 8 p.m. Los visitantes deben ser mayores de 12 años. Renown Children’s Hospital: Open access. For the Pediatric unit and Pediatric Intensive Care Unit (PICU): Los visitantes deben ser mayores de 12 años. For the Neonatal Intensive Care Unit (NICU): Los visitantes deben ser mayores de 18 años. Renown Rehabilitation Hospital: 8 a.m. to 5 p.m. One designated patient supporter is allowed to visit the patient inside their room throughout the duration of their stay. Other loved ones may visit from an exterior window, outside the patient's room. Our care team is also pleased to facilitate bedside virtual visits. In addition to in-person visits, there are many ways to brighten the day of a patient at Renown Hospitals. Puede enviar un mensaje personalizado que se le entregará en persona a su ser querido, llamar al 775-982-4100 para hablar con un paciente, o bien nuestro equipo de atención estará encantado de facilitar visitas virtuales con una computadora o tableta desde la cama del paciente. Renown Health se reserva el derecho de limitar los visitantes en beneficio de los pacientes, las familias, los visitantes o el personal.   About Renown Health Renown Health is Nevada’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 6,500 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®.

Leer más About Renown Health Further Expands Visitor Policy to Two Loved Ones

Renown hospitals are among the first in the country to lift visitor restrictions for patients with COVID-19 and encourage family to be at the patient's bedside. True treasure hunters, Dr. Dave and Darlene found joy in exploring antique shops and garage sales to find damaged or discarded vintage pieces. After hauling the item home, Dave would spend many hours scraping it clean, sanding and refinishing it, until it gleamed and became a polished, functional and beautiful piece of furniture. Every piece in their home rekindles a memory and has a story to tell.  On Thanksgiving, when Dave was too ill to gather around their antique dining room table, Darlene called the ambulance. Dave had been ill with COVID-19 for two weeks and had not been improving. When the EMTs reached her home and asked Darlene what underlying conditions he had, she said, “all of them.” David was seriously ill. Hospitalized for COVID-19, their communications options were limited. The only way Darlene could communicate with Dave was on a video call, or by telephone. Dave pasó 17 días hospitalizado en el Renown Regional Medical Center en Reno. Darlene pasó 17 días esperando junto al teléfono para obtener más información. Darlene dijo que él tenía “días buenos y días malos”, pero pensó que podría estar en casa, sentado en su antigua mesa para la cena de Navidad.  David Ivan Randolph nació en Boston, MA, el 29 de agosto de 1936. He grew up in Roxbury and graduated from the prestigious Boston Latin Boys School. He obtained a Bachelor of Arts in General Psychology, an MA in Experimental Psychology from Northeastern University and a PhD in Sensory Psychology & Physiology from the University of Massachusetts, Amherst. While in university he joined ROTC and upon graduation was commissioned as a First Lieutenant in the Army Medical Specialist Corp. After basic training at the Fort Sam Houston Medical Training School he was assigned as a Captain, Research Psychologist to the US Army at the Pioneering Research Division in Natick, MA. Durante los siguientes 30 años, llevó a cabo una investigaciones sobre la visión en Fort Knox, KY; Filadelfia, PA y, luego, con el recientemente construido Letterman Army Institute of Research (LAIR), División de Riesgos Oculares en el Presidio de San Francisco, CA. David continuó su investigación de la visión en LAIR hasta su jubilación en 1992, cuando el Presidio fue desmantelado. Dr. Randolph’s research findings in flash blindness and night vision made him a sought-after presenter at research conferences in the US and abroad. In a PBS documentary he was interviewed as part of the team that developed goggles that protect soldiers from laser eye damage. El Dr. David Randolph perdió su lucha contra la COVID-19 el 13 de diciembre de 2020, y murió mientras dormía en una cama de hospital. When Darlene wrote his obituary for the newspaper, she gave thanks to the “tremendous nurses and doctors at Renown Regional Medical Center, for providing his care during a time when family could not be with him.” Darlene wished she could have been there. Over their 45-year marriage, she had always been there. Darlene said, “I had always been at his bedside, as his advocate, to help communicate and straighten things out.” As a registered dietician, she worked in hospitals and knew the protocol. She knew, like hospitals across the globe, Renown had restricted family members from visiting in order to stop the spread of the virus- to other patients, staff and their family members. Still, she wished she could have spent more time with him. On Christmas Eve, she sat down and wrote to Dr. Anthony Slonim, president and chief executive officer of Renown Health in Reno, NV. “Dear Doctor Slonim, as the wife of a COVID patient who recently passed away in your hospital, I want to express my thanks to you and your staff for the care he was given in the last days of his life. I am aware that the nurses and staff are working under dangerous conditions and risking their health and lives by caring for multiple COVID patients. The staff was gracious, concerned and did everything they could for my husband and myself.” She continued, “I know procedures are changing every hour to try to stay ahead of this dangerous virus and I am sharing my experiences hoping they will be helpful when establishing policies that impact families.” Darlene explained that despite receiving assurances that Dave’s nurse or even a doctor would call daily, sometimes they would forget. She explained in her letter, “how important it was, in these times when family cannot visit, and has only infrequent communication and is anxiously waiting at home for word of their loved one, how much it means to get a call from someone caring for him at the hospital.” Darlene asked, “If there is any way you can help to assure that nurses have time to make calls or assist patients to make calls, because it is an important part of patient care.”  After receiving her letter, Dr. Slonim called Mrs. David Randolph, to thank her, to offer his sympathies and to ask if Renown could help in any way. Darlene asked if he might reconsider allowing families to visit hospital patients being treated for COVID-19. Dr. Slonim, who had also lost his father to COVID-19 back in April at a hospital in New Jersey, asked his leadership team to review Mrs. Randolph’s request and make a recommendation. The hospital leadership team made a recommendation to Dr. Slonim that was immediately approved. As the COVID-19 situation has evolved, the policy has as well. Con un alto porcentaje del personal hospitalario de Renown vacunado contra la COVID-19, el descenso de las hospitalizaciones de pacientes con COVID-19 y la comprensión de que la mejor comunicación es la que se produce en persona, a partir de la mañana del miércoles, 27 de enero de 2021, los hospitales y consultorios médicos de Renown permiten visitantes limitados para todos los pacientes, incluidos los diagnosticados con COVID-19. Renown continues to have extra safety measures in place to protect the health of patients, visitors and healthcare employees, and as the situation changes with COVID-19, these guidelines are subject to change. “As of today, one healthy adult Patient Supporter may now accompany every patient to their Renown medical visit or hospital stay,” Tony Slonim, MD, DrPH, President & CEO of Renown said, “We live by our values of caring, integrity, collaboration and excellence. We thank Darlene for reminding us that the best care is ‘person-centered care,’ an approach that embraces the perspective of the patient and their loved ones, while promoting a healthy, encouraging environment for caregivers and addressing the health needs of our community.”  “At Renown, the definition of "family" is defined by the patient,” says Debra Adornetto-Garcia, DNP, RN, NEA-BC, AOCN, Chief Nursing Officer, Acute Services. “Our patients may designate anyone they choose as their Patient Supporter. The Patient Supporter is incredibly important and part of the care team. The Patient Supporter will be asked to partner with the patient’s health care team to assist in communicating to other family members and friends, participating in training and education activities and assisting the patient with complying with care and medication instructions.” “When it comes to healing and recovery, everyone's role is important,” emphasizes Paul Sierzenski, MD, MSHQS, CPE, FACEP, Chief Medical Officer, Acute Services. “What we can do together to support patient care and excellent outcomes is greater than what any of us can do alone. This belief shapes our work, our services and the care we provide to patients, their families and friends at Renown.” “I am pleased that Renown Health has modified the visitation policies so that each patient can have a designated visitor. As a former ICU patient and current ICU physician, I know the importance of having a loved one’s support in the hospital and I am thrilled we are able to accommodate this incredibly important aspect of patient care,” says Jacob B Keeperman, MD, FACEP, FAAEM, FAEMS, FCCM, Medical Director, Renown Regional Transfer and Operations Center, Intensivist. When Darlene was told that her letter inspired this shift in visitor policies for patients with COVID-19, she was very pleased and said, “I have always tried to think of ways I could help other families, especially those senior couples where one has been hospitalized and the other is home. My wish is to help others.” De acuerdo con las pautas nacionales, a partir del 1/27/2021, una persona de apoyo al paciente podrá acceder a Renown Regional Medical Center y a Renown South Meadows Medical Center según se indica a continuación: El horario de visitas para todos los pacientes, incluidos los diagnosticados con COVID-19, se extenderá de 8 a. m. a 8 p. m. (anteriormente de 3 a 8 p. m.). All patients are now encouraged to designate up to two Patient Supports. Due to space constraints, we ask that Patient Supports visit one at a time. Patients will provide Names of up to two Patient Supporters during patient admission/registration. Patient Supporter names will be entered into the patient's electronic medical record for patient privacy and security. Renown Children’s Hospital: Open access. (Two parents and/or guardians may be designated as Patient Supporters, however, due to current space constraints, we ask that you visit one at a time). Para obtener información detallada sobre el programa de persona de apoyo al paciente, visite https://www.renown.org/interact/.   About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project® . Visite renown.org para obtener más información.

Leer más About Reno Widow Inspires New Patient Supporter Visitor Policy

Renown Health's Dr. Christopher Rowan recently joined a distinguished panel of experts on the "Game Changers in Medicine" podcast to discuss the science behind the discovery of warfarin. Renown Health Cardiologist Dr. Christopher Rowan was just featured on an episode of Game Changers in Medicine, a groundbreaking medical history podcast from Dramatic Health about some of the world’s most significant medical discoveries. The episode, Warfarin: How a rat poison became one of the world's most widely prescribed drugs, dives into the fascinating history of Warfarin and its life-saving effects on humans.  During the episode, Dr. Rowan, whose research focus is heart disease and atherosclerosis, is joined by experts Kevin Walters, Historian and Strategic Research Coordinator at the Wisconsin Alumni Research Foundation (WARF); and Ramya M. Rajagopalan, Ph.D. of the Institute for Practical Ethics at UC San Diego. Listen to the episode now or download it wherever you listen to podcasts.  History of Warfarin Warfarin prevents blood clots from forming or expanding. The drug is especially important for individuals who have experienced a heart attack or stroke, or are at risk of experiencing either. However, the backstory of the drug is rather fascinating.  Beginning in the 1920s, an unknown disease was killing cattle throughout the U.S. and Canada. Desesperado por encontrar una solución, un granjero condujo 200 millas hasta la University of Wisconsin con una vaca muerta, fardos de heno estropeado y una lata de leche con sangre sin coagular. El hombre se cruzó con un científico, cuyo equipo se propuso determinar el componente hemorrágico del heno estropeado, lo que dio como resultado una serie de descubrimientos médicos que revolucionarían la medicina. Tras aprender más sobre la warfarina y cómo la vitamina K podría revertir sus propiedades anticoagulantes, los médicos recetaron por primera vez la medicina para uso humano en 1954. Probablemente sea muy conocida por salvar al presidente Dwight D. Eisenhower después de que sufrió un ataque cardíaco en 1955. Today, Warfarin continues to saves millions of lives each year. “Before blood thinners like Warfarin, people would experience strokes, blood clots in their lungs, blood clots in their legs, blood clots in their hearts, along with countless other clotting disorders - these conditions likely cutting their lifespans short,” Dr. Rowan said during the podcast. “Warfarin revolutionized the treatment of patients who suffer from heart attacks and strokes, helping them to live normal and healthy lives. The drug changed medicine forever and helped make incredible innovations such as mechanical heart valves a reality.” Interview Opportunity Dr. Rowan is available for interviews to discuss the importance of this unique medical discovery and the positive impact it has on many of the patients he treats every day. Envíe un correo electrónico a news@renown.org o llame al 775-691- 7308 para coordinar una entrevista. Acerca de Renown Health Renown Health es la red de atención médica integrada de propiedad y administración local y sin fines de lucro más grande de la región, que presta servicios en Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project® . Visite renown.org para obtener más información. About Dramatic Health Dramatic Health, a national healthcare video company, is the producer of the six-part podcast series Game Changers in Medicine. The series premiered in July with an episode about Vitamin K and an enterprising Boston house doctor. The August episode showcased the creation of a smallpox vaccine and its parallels to today's urgent search for a COVID-19 vaccine. Game Changers in Medicine se clasificó en el puesto 27 de los podcasts de Apple en la categoría “Ciencias de la vida en los Estados Unidos” de acuerdo con Chartable al 21 de agosto de 2020. Los dos episodios, un resumen de la serie y material adicional sobre la serie de podcasts están disponibles en www.gamechangersinmedicine.com y se puede acceder a estos materiales desde la plataforma que utilice para escuchar podcasts.

Leer más About Renown Cardiologist Shares Insight on Warfarin

El enfoque basado en la comunidad del Healthy Nevada Project revela que hasta un 90 % de los riesgos de padecer afecciones genéticas de Nivel 1 de los CDC no se detecta cuando se usan pautas de atención clínica. In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke. En 2018, el Healthy Nevada Project® (el mayor estudio de salud poblacional basado en la comunidad que combina datos genéticos, clínicos, ambientales y sociales) comenzó a notificarles a los participantes del estudio que habían dado su consentimiento sobre ciertas variantes genéticas que los predisponían a padecer las afecciones genéticas de Nivel 1 de los Centros para el Control y la Prevención de Enfermedades (Centers for Disease Control and Prevention, CDC). The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality. Los resultados iniciales de casi 27,000 participantes del estudio mostraron que el 90 % de los portadores de las afecciones genéticas de Nivel 1 de los CDC no había sido previamente identificado en un entorno clínico. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care. “Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study. “Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at risk individuals.” Del grupo de 26,906 participantes del Healthy Nevada Project® que el equipo de investigación de Grzymski estudió, 358 (el 1.33 %) eran portadores de afecciones de Nivel 1 de los CDC. Sin embargo, solo el 25 % de esas personas cumplían las pautas clínicas para realizarse exámenes de detección genética. Además, más del 20 % de los portadores ya tenía un diagnóstico de enfermedad relacionada con la afección genética subyacente. “We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.” En particular, el estudio descubrió que de los 273 participantes que eran portadores de las afecciones genéticas de Nivel 1 de los CDC y que tenían información de registros clínicos, solo 22 personas mostraron sospechas previas de tener estas afecciones genéticas subyacentes. “For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be life changing.” According to the CDC, early detection and intervention of the Tier 1 genetic conditions could have a meaningful potential for clinical action ability and a positive impact on public health. El Healthy Nevada Project®, que se lanzó en 2016, ofrece pruebas genéticas gratuitas a todos los residentes de Nevada, mayores de 18 años, interesados en obtener más información sobre su salud y perfil genético. Con más de 50,000 participantes del estudio inscritos en cuatro años, el Healthy Nevada Project® se ha convertido en el estudio genético de más rápida inscripción del mundo. For more about the Healthy Nevada Project® please visit healthynv.org     Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at Healthynv.org. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+Ⓡ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. In response to the COVID-19 public health crisis, Helix has launched a sensitive and scalable end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country. Obtenga más información en www.helix.com.

Leer más About Los exámenes de detección genética poblacionales demuestran que identifican de manera eficiente un aumento en el riesgo de padecer enfermedades hereditarias

Presented by the Desert Research Institute and Renown Health, DANA will help people learn more about the Healthy Nevada Project® and their own unique, genetic health traits What is the Healthy Nevada Project®? What are the benefits of joining this research study? How can I find out if I carry genes for health risks like heart disease, hereditary breast and ovarian cancer syndrome and Lynch syndrome? What if a holographic avatar, powered by artificial intelligence (AI), could answer all these questions and more? DANA has all the answers, she is a virtual assistant with “DNA” in her name, presented by the Renown Institute for Health Innovation (Renown IHI), a collaboration between Renown Health and the Desert Research Institute (DRI). This life-sized, holographic avatar will greet individuals outside Renown Regional Medical Center’s Sierra Café, and talk to them about the Healthy Nevada Project, the world’s largest community-based genetic population health study. Los representantes de medios de comunicación están invitados a reunirse con DANA esta mañana, desde las 10 a.m. hasta el mediodía. Responda a este correo electrónico o llame al (775) 691-7308 para coordinar una reunión. “Unfortunately, Nevada ranks among the lowest in the nation for health outcomes—and we are working to change that,” said Anthony Slonim, M.D., D.Ph., president and CEO of Renown Health and president of Renown Institute for Health Innovation. “Through the Healthy Nevada Project® , our goal is to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile. Thanks to this advanced technology, DANA will offer people a personalized explanation of the Project, and help them take the next step to better understand their health, and their health risks, so they can modify their behavior and ultimately, live a healthier, happier life.” Con más de 51,000 participantes del estudio inscritos hasta la fecha, el Healthy Nevada Project® se considera el estudio genético de más rápida inscripción del país. The Project is also the first of its kind to return clinical results to study volunteers, which means participants can learn their genetic risks tied to heart disease and certain cancers, as well as lifestyle changes that could potentially help reduce their risk and prevent disease. Furthermore, participants can choose to share their information with their medical provider to improve and enhance their medical care. “We are always happy to engage with our study participants and look forward to having them meet and engage with DANA,” said Joseph Grzymski, Ph.D., research professor at DRI, principal investigator of the Healthy Nevada Project® and chief scientific officer for Renown Health. “At a time of physical distancing and limiting human contact where possible, using tools like an avatar and AI are important for communicating, whether it be for genetics, vaccinations or other important health information.” Visitors can interact with DANA through a touch screen (cleaned and sanitized after every encounter) to learn more about the study, enter their contact information and schedule an appointment to join the free genetics study or receive more information about their test results. Kiosk visitors are asked to maintain physical distance guidelines and use the hand sanitizer and Sani Wipes available next to the kiosk.     Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org.

Leer más About Presentación de Dana, el nuevo quiosco holográfico tamaño real del Renown Institute for Health Innovations

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. En virtud de los términos del acuerdo de colaboración y licencia, Gilead proporcionará fondos al Renown IHI para secuenciar y analizar el ADN de 15,000 personas que viven con EHNA o con enfermedad de hígado graso no alcohólico (EHGNA), así como de una cohorte de control de 40,000 personas en el estado de Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health es la red de atención médica más completa e integrada de Nevada y mantiene registros médicos electrónicos para 1.02 millones de pacientes registrados. En 2016, Renown Health y el Desert Research Institute crearon el Healthy Nevada Project (HNP), el primer estudio de salud poblacional basado en la comunidad del país. En 2017, el HNP comenzó una sociedad con Helix para aprovechar sus servicios de salud poblacional, la secuenciación Exome+™ y las herramientas de participación del consumidor. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. El HNP actualmente tiene 40,000 participantes. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. La EHNA es más frecuente en personas con ciertas afecciones, que incluyen obesidad y diabetes tipo 2. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead opera en más de 35 países alrededor del mundo, con sede central en Foster City, California. Para obtener más información sobre Gilead Sciences, visite el sitio web de la empresa en www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Mediante el uso de su ensayo Exome+™ de propiedad exclusiva, un exoma de tipo panel mejorado con más de 300,000 regiones no codificantes informativas, Helix ofrece a los sistemas de salud una solución escalable que permite el descubrimiento de información genética médicamente relevante y que potencialmente puede salvar vidas. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Obtenga más información en www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. Estos y otros riesgos se describen en detalle en el Informe Trimestral de Gilead en el Formulario 10-Q para el trimestre que finalizó el 31 de marzo de 2019, presentado ante la Comisión de Bolsa y Valores de los EE. UU. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Leer más About Gilead Sciences y el Renown Institute for Health Innovation anuncian una colaboración estratégica para promover la comprensión de la esteatohepatitis no alcohólica (EHNA)